MY ACCOUNT | NEWSLETTER |

PetSmart Charities commits $15M to vet care


PetSmart Charities, the charitable arm of PetSmart, has pledged to help to address inadequate veterinary care with a $15 million commitment. The 2022 funding will be used to help veterinary organizations and community-based groups aimed at improving access to veterinary care.

Grants and “innovative delivery models” will be used to alleviate short term barriers to veterinary care and to build solutions that will address the issues in access within communities. In particular, pet owners cite cost as the top barrier to providing adequate and preventive veterinary care as well as what are called “veterinary care deserts” where rural areas and communities of color do not have local access to veterinary care.

"We are committed to supporting people and pets and are working to break down the barriers that prohibit pet families from living happy and healthy lives together," said Aimee Gilbreath, president of PetSmart Charities. "We have a unique opportunity to drive immediate and real change for pets through our grant programs. By working with partners and leaders in the veterinary space, we hope to help build low-cost veterinary care models that can be replicated across the country to meet the tremendous need for affordable care."

An example of one of the grant recipient’s is an organization, Emancipet, a nonprofit which increases access to affordable veterinary care. PetSmart Charities has been involved with Emancipet since 2017, has aided in scaling its organization, and allowed for additional locations of its clinics. 

“Thanks to the continued generosity of PetSmart Charities in funding the opening of two of our newest clinics in Houston and Philadelphia, Emancipet is one step closer to achieving our vision of ensuring that everyone in the United States will have access to veterinary care they can afford,” said Amy Mills, chief executive officer of Emancipet.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Advancing the 3Rs: innovation, implementation, ethics and society

Like0
Dislike0

Automated Knowledge-Based Radiation Treatment Planning in Canine and Feline Nasal Tumors

Like0
Dislike0

Does Lung Function Imaging Modality Have a Dosimetric Impact On Functional Avoidance Treatment Planning: Assessment Using Prospective Clinical Trial Data

Like0
Dislike0

One Committed and Caring NC State Veterinary Student, So Many Choices

Like1
Dislike0

Dentalis Earns 5 VOHC® Seals, Positioning for Global Expansion in Animal Health

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top